v3.26.1
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 2,720,278   $ 2,720,278   $ 2,683,543
Total assets 6,106,946   6,106,946   5,769,534
Current liabilities 1,637,140   1,637,140   1,531,664
Total liabilities 3,359,177   3,359,177   3,001,862
Total joint venture equity 2,631,419   2,631,419   2,642,020
Investments in and advances to unconsolidated joint ventures 153,328   153,328   148,640
Revenue 1,575,867 $ 1,584,323 3,067,043 $ 3,138,683  
Costs 1,280,629 1,235,970 2,414,385 2,436,347  
Net (loss) income attributable to Parsons Corporation (15,219) 55,230 37,707 121,433  
Equity in losses of unconsolidated joint ventures (33,748) (642) (27,592) (1,329)  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 1,351,657   1,351,657   1,549,367
Noncurrent assets 416,201   416,201   439,496
Total assets 1,767,858   1,767,858   1,988,863
Current liabilities 856,070   856,070   1,046,970
Noncurrent liabilities 463,791   463,791   469,833
Total liabilities 1,319,861   1,319,861   1,516,803
Total joint venture equity 447,997   447,997   472,060
Investments in and advances to unconsolidated joint ventures 153,328   153,328   $ 148,640
Revenue 436,941 425,795 731,944 950,351  
Costs 490,072 391,301 766,968 912,177  
Net (loss) income attributable to Parsons Corporation (53,131) 34,494 (35,024) 38,174  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Equity in losses of unconsolidated joint ventures $ (33,748) $ (642) $ (27,592) $ (1,329)